Financial Summary (All financials)
In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
Revenues | 187.7 | 142.2 | 111.1 | 83.5 | 60.9 |
Revenue growth | 32.0% | 28.0% | 33.1% | 37.2% | |
Cost of goods sold | 59.7 | 42.1 | 31.9 | 20.6 | 16.7 |
Gross profit | 128.0 | 100.2 | 79.2 | 62.9 | 44.2 |
Gross margin | 68.2% | 70.4% | 71.3% | 75.4% | 72.6% |
Sales and marketing | 77.9 | 61.8 | 48.4 | 35.9 | 29.3 |
Research and development | 22.0 | 14.0 | 11.2 | 7.6 | 4.2 |
General and administrative | 34.7 | 23.1 | 19.4 | 11.5 | 8.4 |
EBITA | -7.9 | 0.6 | -1.9 | 7.9 | 2.3 |
EBITA margin | -4.2% | 0.4% | -1.7% | 9.5% | 3.8% |
Amortization of intangibles | 3.4 | 0.9 | | | |
EBIT | -11.3 | -0.2 | -1.9 | 7.9 | 2.3 |
EBIT margin | -6.0% | -0.2% | -1.7% | 9.5% | 3.8% |
Pre-tax income | -14.5 | 0.9 | -0.9 | 8.7 | 2.6 |
Income taxes | 4.4 | -0.9 | 2.3 | 4.4 | 2.7 |
Tax rate | | | | 50.6% | 107.2% |
Net income | -18.8 | 1.8 | -3.2 | 4.3 | -0.2 |
Net margin | -10.0% | 1.3% | -2.9% | 5.2% | -0.3% |
|
Diluted EPS | ($0.45) | $0.04 | ($0.13) | $0.12 | ($0.01) |
Shares outstanding (diluted) | 41.6 | 43.2 | 25.3 | 34.8 | 16.8 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|